Sales decline 6.50% to Rs 7.62 crore
Net profit of Beryl Drugs rose 121.43% to Rs 0.31 crore in the quarter ended December 2023 as against Rs 0.14 crore during the previous quarter ended December 2022. Sales declined 6.50% to Rs 7.62 crore in the quarter ended December 2023 as against Rs 8.15 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales7.628.15 -7 OPM %10.378.71 -PBDT0.680.59 15 PBT0.370.37 0 NP0.310.14 121Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content